N,N'-(5,6,7,12,13,14-HEXAHYDRO-4,11-DIMETHOXY-6,7,13,14-TETRAOXOQUINO(2,3-B)ACRIDINE-1,8-DIYL)BISACETAMIDE
UNII BBE3EPJ2JA
Substance Identification & Data
This profile provides standardized clinical and technical data for N,n'-(5,6,7,12,13,14-hexahydro-4,11-dimethoxy-6,7,13,14-tetraoxoquino(2,3-b)acridine-1,8-diyl)bisacetamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BBE3EPJ2JA.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 63404-69-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H20N4O8 BMBSQPCJMGWUPA-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N,n'-(5,6,7,12,13,14-hexahydro-4,11-dimethoxy-6,7,13,14-tetraoxoquino(2,3-b)acridine-1,8-diyl)bisacetamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.